AbCellera Biologics Inc. Common Shares (ABCL)
ABCL trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$12.61
-0.20% on the day
Market cap
$4.1B
Mid cap
Revenue · 2025
$75.1M
+160.6% on 2024
Net income · 2025
-$146.4M
-194.9% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ABCL on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Canada |
| IPO year | 2020 |
| SEC CIK | 0001703057 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | A1 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $75.1M |
| Net income | -$146.4M |
| Operating income | -$217.1M |
| Net margin | -194.9% |
| Operating margin | -289.0% |
| Revenue growth | +160.6% |
| Cash | $128.5M |
| Total assets | $1.4B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 54.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-08-13 |
| Latest annual report | 10-K | 2026-02-24 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-08-13 |
| Latest proxy | DEFA14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 322 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -3.5% |
| 1 month | +8.5% |
| 3 months | +101.1% |
| Year to date | +262.1% |
| 1 year | +118.4% |
| From 52-week high | -16.4% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| INDV | Indivior Pharmaceuticals Inc. | $35.42 | -1.77% | $4.2B |
| EWTX | Edgewise Therapeutics Inc. | $36.28 | -5.64% | $3.9B |
| DNTH | Dianthus Therapeutics Inc. | $77.58 | -4.89% | $4.3B |
| TNGX | Tango Therapeutics Inc. | $22.22 | -8.07% | $3.7B |
| TLX | Telix Pharmaceuticals Limited | $10.92 | -3.28% | $3.7B |
| OGN | Organon & Co. Common Stock | $13.77 | 0.00% | $3.6B |
| LEGN | Legend Biotech Corporation | $17.88 | +0.45% | $3.5B |
| MANE | Veradermics Incorporated | $116.26 | -5.02% | $4.9B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier